Search Results 2271-2280 of 16716 for praluent side afects

  1. Clinical trials - Gastroenterology and Hepatology

    ... adverse events reported by National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. ... A Study to Evaluate the Effects ...

  2. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  3. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  4. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  5. A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical Treatment CTEPH - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  6. Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  7. Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  8. Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  9. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  10. Hematology - Clinical trials

    This phase I trial studies the best dose and side effects of recombinant ... adverse effects of cancer therapy (single or multiple) and stem cell transplant.